Skip to main content

Table 5 Summary of CD8+, CD4+ and FOXp3+ T cell in pre- and post-treatment biopsies, as recorded in tumor, and in the stroma

From: A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer

Group

Variable CI t

n complete both

Mean difference

p value t test

Overall

Tumor log(CD8)

[− 0.63, 0.12]

tumor.CD8

13

− 0.256

0.16

Tumor log(CD8/CD4)

[− 0.37, 0.48]

tumor.CD8.CD4

13

0.054

0.79

Tumor Foxp3

[− 0.81, 0.07]

tumor.Foxp3

13

− 0.371

0.09

Stroma Foxp3

[− 0.79, 0.34]

stroma.Foxp3

13

− 0.225

0.40

Aza

Tumor log(CD8)

[− 1.28, 1.02]

tumor.CD8

4

− 0.13

0.74

Tumor log(CD8/CD4)

[− 0.68, 0.91]

tumor.CD8.CD4

4

0.112

0.68

Tumor Foxp3

[− 1.96, 1.88]

tumor.Foxp3

4

− 0.04

0.95

Stroma Foxp3

[− 1.91, 2.03]

stroma.Foxp3

4

0.058

0.93

Rom

Tumor log(CD8)

[− 1.35, 0.16]

tumor.CD8

5

− 0.596

0.09

Tumor log(CD8/CD4)

[− 1.47, 1.11]

tumor.CD8.CD4

5

− 0.181

0.72

Tumor Foxp3

[− 1.21, 0.19]

tumor.Foxp3

5

− 0.513

0.11

Stroma Foxp3

[− 1.84, 0.84]

stroma.Foxp3

5

− 0.501

0.36

Aza + Rom

Tumor log(CD8)

[− 0.62, 0.70]

tumor.CD8

4

0.043

0.85

Tumor log(CD8/CD4)

[− 0.30, 0.88]

tumor.CD8.CD4

4

0.289

0.22

Tumor Foxp3

[− 0.88, − 0.18]

tumor.Foxp3

4

− 0.525

0.02

Stroma Foxp3

[− 0.78, 0.45]

stroma.Foxp3

4

− 0.164

0.46